Background: Biospecimens collected during medical research and the data derived from these materials represent a valuable resource of genetic and genomic information that can be used in biopharmaceutical drug development. The growing industry trend towards personalized medicine combined with reductions in research funding is creating the need for organizations to focus on optimization of sample asset inventories and integration of high-quality sample bioprocessing methods in order to maximize future research and reduce costs.
展开▼
